Neurocognitive function following (chemo)radiotherapy for nasopharyngeal cancer and other head and neck cancers: A systematic review
Zsuzsanna Iyizoba-Ebozue, Louise Murray(Leeds Teaching Hospitals NHS Trust), Florien Boele(University of Leeds), Emma Hall(Institute of Cancer Research), David Thomson(The Christie NHS Foundation Trust), Finbar Slevin(University of Leeds), Robin Prestwich, Matthew Lowe, Sarah Brown(University of Leeds), J. Lilley(Leeds Teaching Hospitals NHS Trust)
Cited by 10
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912